@article{684eb127385440738ccf555f32a034e7,
title = "A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)",
keywords = "Prospective Studies, Humans, Middle Aged, Aged, 80 and over, Ipilimumab/therapeutic use, Adult, Female, Aged, Nivolumab/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Breast Neoplasms/drug therapy",
author = "Sylvia Adams and Megan Othus and Patel, \{Sandip Pravin\} and Miller, \{Kathy D.\} and Rashmi Chugh and Schuetze, \{Scott M.\} and Chamberlin, \{Mary D.\} and Haley, \{Barbara J.\} and Storniolo, \{Anna Maria V.\} and Reddy, \{Mridula P.\} and Anderson, \{Scott A.\} and Zimmerman, \{Collin T.\} and O{\textquoteright}Dea, \{Anne P.\} and Mirshahidi, \{Hamid R.\} and Ahnert, \{Jordi Rodon\} and Brescia, \{Frank J.\} and Olwen Hahn and Raymond, \{Jane M.\} and Biggs, \{David D.\} and Connolly, \{Roisin M.\} and Elad Sharon and Korde, \{Larissa A.\} and Gray, \{Robert J.\} and Edward Mayerson and Melissa Plets and Blanke, \{Charles D.\} and Chae, \{Young Kwang\} and Razelle Kurzrock",
note = "{\textcopyright}2021 American Association for Cancer Research.",
year = "2022",
month = jan,
day = "15",
doi = "10.1158/1078-0432.CCR-21-2182",
language = "English",
volume = "28",
pages = "271--278",
journal = "Clinical Cancer Research",
issn = "1078-0432",
number = "2",
}